Gold nanoparticles conjugated with trastuzumab enhance ovarian cancer cell death, particularly in drug-resistant cases, ...

Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally ...

Silexion's SIL204 showed strong KRAS-targeted inhibition across pancreatic, colorectal, and lung cancer cells, supporting its ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...

Think chocolate, eggs, and potatoes are unhealthy? Think again! Discover surprising foods once labeled “bad” that actually ...

As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and ...

GSK tops Q2 estimates with growth in vaccines and specialty drugs, raises 2025 forecast amid progress in major late-stage ...

Researchers at Sylvester Comprehensive Cancer Center reveal how body composition analysis predicts treatment response in ...

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Nuvation Bio Inc. (NYSE:NUVB) is one of the best biotech penny stocks to buy right now. In a report released on July 7, Leonid Timashev from RBC Capital maintained a Buy rating on Nuvation Bio Inc.